PRN Firocoxib Tablets

Key Features:

• Effective Pain Relief – Helps relieve pain and inflammation associated with osteoarthritis and orthopedic conditions.
• Anti-Inflammatory Action– Contains firocoxib, a COX-2 selective NSAID that targets inflammation without affecting protective stomach enzymes.
• Once-Daily Dosing – Convenient daily administration helps maintain consistent relief.
• Supports Mobility – Improves comfort, mobility, and quality of life in aging or recovering animals.
• Veterinary Approved – Formulated specifically for canine and equine use under veterinary guidance.
• Palatable Formulations – Easy-to-administer tablets designed to promote compliance.

Directions for Use:

For Dogs

• Dosage & Administration: Administer exactly as prescribed by your veterinarian, typically once daily.
• With or Without Food: Tablets can be given with or without food, depending on your dog’s preference and tolerance.
• Hydration: Ensure your dog has access to clean, fresh water at all times.
• Monitoring: Regular vet visits are recommended to check kidney, liver, and gastrointestinal health during treatment.

Warnings:
Not for use in humans. Keep this and all medications out of the reach of children. Consult a physician in case of accidental ingestion by humans.

Keep Firocoxib Chewable Tablets for Dogs in a secure location out of reach of dogs, cats, and other animals to prevent accidental ingestion or overdose.

For Horses

• Dosage & Administration: Administer once daily according to your veterinarian’s instructions.
• Feeding Guidelines: Tablets can be given directly or mixed with a small portion of feed for easier administration.
• Duration: Do not exceed the recommended duration of use unless under veterinary supervision.
• Monitoring: Regular monitoring is recommended to assess your horse’s response and overall health, particularly kidney and GI function.

Precatuions: Horses should undergo a thorough history and examination before initiation of NSAID therapy. Appropriate laboratory tests should be conducted to establish hematological and serum biochemical baseline data before and periodically during administration of any NSAID. Clients should be advised to observe for signs of potential drug toxicity and be given a Client Information Sheet with each prescription. See Information for Owner or Person Treating Horse section of this package insert.

Treatment with Firocoxib Tablets for Horses should be terminated if signs such as inappetence, colic, abnonnal feces, or lethargy are observed.

As a class, cyclooxygenase inhibitory NSAIDs may be associated with gastrointestinal, renal, and hepatic toxicity. Sensitivity to drug-associated adverse events varies with the individual patient. Horses that have experienced adverse reactions from one NSAID may experience adverse reactions from another NSAID. Patients at greatest risk for adverse events are those that are dehydrated, on diuretic therapy, or those with existing renal, cardiovascular, and/or hepatic dysfunction. Concurrent administra­tion of potentially nephrotoxic drugs should be carefully approached or avoided. NSAIDs may inhibit the prostaglandins that maintain normal homeostatic function. Such anti-prostaglandin effects may result in clinically significant disease in patients with underlying or pre-existing disease that has not been previously diagnosed. Since many NSAIDs possess the to produce gastrointestinal ulcerations and/ or gastrointestinal perforation, concomitant use of Firocoxib Tablets for Horses with other inflammatory drugs, such as NSAIDs or should be avoided.

The concomitant use of protein bound drugs with Firocoxib Tablets for Horses has not been studied in horses. The influence of concomitant drugs that may inhibit the metabolism of Firocoxib Tablets for Horses has not been evaluated. Drug compatibility should be monitored in patients requiring adjunctive therapy.

The safe use of Firocoxib Tablets for Horses in horses less than one year in age, horses used for breeding, or in pregnant or lactating mares has not been evaluated.

Consider appropriate washout times when switching from one NSAID to another NSAID or corticosteroid.